Anchor Investment Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1634149
COLUMBIA, SC
Position in VRTX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$174,597
-$49,816 QoQ
Shares Held
391
-21.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $1,529,617 across 11 Biotechnology names. VRTX ranks #2 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,819 | $932,722 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
391 | $174,597 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
4,700 | $156,134 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184 | $142,165 | |
| 5 | INCY |
Incyte Corp
|
500 | $47,060 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
108 | $32,072 | |
| 7 | EXEL |
Exelixis, Inc.
|
600 | $25,734 | |
| 8 | ARGX |
Argenx SE
|
20 | $14,605 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $174,597 | 391 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $224,413 | 495 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $934,844 | 2,387 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $719,888 | 1,617 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $782,984 | 1,615 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $566,196 | 1,406 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $736,221 | 1,583 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $51,090 | 109 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $894,959 | 2,141 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $802,793 | 1,973 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $582,812 | 1,676 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $456,779 | 1,298 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $209,521 | 665 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $180,198 | 624 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $2,895 | 10 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $2,817 | 10 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $2,609 | 10 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $2,196 | 10 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $1,813 | 10 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $2,016 | 10 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $147,199 | 685 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $37,814 | 160 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $12,245 | 45 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $2,903 | 10 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||